ANXA2 and prostate carcinoma: Microarray analysis revealed that annexin A2 (along with annexin A1, A4, A7 and A11) was significantly down-regulated in metastatic androgen-independent prostate cancer patients when compared to hormone-naive prostate cancers and non-cancerous prostate tissues [210].